Francois Delvoye and Jean‐Philippe Désilles: Neutrophil Activation Affects Acute Ischemic Stroke Clinical Outcomes?
Francois Delvoye, Lecturer at the University of Liège (Belgium) and Research Coordinator at the Biological Resource Center of the Rothschild Foundation Hospital (Paris), shared an insightful post on LinkedIn:
”Check out our lab’s latest publication in JAHA!
Neutrophil activation at 24 hours after mechanical thrombectomy for acute ischemic stroke is correlated with 3-month clinical outcome.
Another argument for targeting neutrophil activation — as investigated in the NETs-Target clinical trial (NCT04785066), led by Prof. Jean-Philippe DESILLES at the Fondation Adolphe de Rothschild!”
Read the full article here.
Article: Neutrophil Activation 24 Hours After an Endovascular Therapy–Treated Acute Ischemic Stroke Is Associated With 3‐Month Clinical Outcome
Authors: François Delvoye, Benjamin Maier, Mialitiana Solonomenjanahary, Julien Labreuche, Lucas Di Meglio, Véronique Ollivier, Pierre Seners, Michel Piotin, Raphaël Blanc, Simon Escalard, Mikael Mazighi, Benoit Ho‐Tin‐Noé, Jean‐Philippe Désilles

Stay updated on the latest scientific advancements in the field of stroke with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight